Accelerate Diagnostics (axdx 5 12/15/26)
13F holders, Q3 2024 (September 30)1holders
0new positions
0sold out
$0.32avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Accelerate Diagnostics (axdx 5 12/15/26) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Wolverine Asset Management LLC ($1.7M).
- Company
- Accelerate Diagnostics (axdx 5 12/15/26)
- CUSIP
- 00430HAC6
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 871,242 shares bought, net +871,242 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Wolverine Asset Management LLC | 0.16% | Add +20.3% | 5,154,266 | $1.7M |
"% of holder's portfolio" is ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26)'s weight in each manager's 13F, not the share of Accelerate Diagnostics (axdx 5 12/15/26) the manager owns.